loader

World Tenders & Procurement Opportunities

Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient pomalidomide (ATC code according to WHO: L04AX06) - 565568

World Biggest Tenders Source

This tender with title Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient pomalidomide (ATC code according to WHO: L04AX06) - 565568 has been published on Bidding Source portal dated 23 Sep 2024 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient pomalidomide (ATC code according to WHO: L04AX06) - 565568
Invitation for Bids
Germany
23 Sep 2024
31 Oct 2025
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient sulfasalazine (M01CX02) within the framework of a so-called open-house model. - 555167 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient erythropoietin (B03XA01) within the framework of a so-called open-house model. - 558570 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 554073 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient ebastine (R06AX22) within the framework of a so-called open-house model. - 555891 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient filgotinib (L04AF04) within the framework of a so-called open-house model. - 557133 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient sultiam (N03AX03), only film-coated tablets, within the framework of a so-called open-house model. - 558565 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient imiquimod (D06BB10) within the framework of a so-called open-house model. - 556187 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient golimumab (L04AB06) within the framework of a so-called open-house model. - 556456 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient bosutinib (L01EA04) within the framework of a so-called open-house model. - 556462 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient edoxaban (B01AF03) within the framework of a so-called open-house model. - 556830 Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans